Citi Pharma Ltd.PSX: CPHL

Financial Results for the year ended

· Issued by Citi Pharma Ltd.

$i¿i



gitiPharma Limited



October 02, 2025 at t2:30 Pm 588 Block Q Phase 2 Johar Town, Lahore Lahore have Recommended the the

  1. Right Shares

  2. Any other entitlement/corporate anion

nii nii

Statement of Financial Position, Statement of Profit or loss and Other Comprehensive Income, Statement of Changes in Equity and Statement of Cash flows of the Company for the year ended June 30, 2025, are enclosed as annexures.

The Annua) General Meeting (AGM) of the Company will be held on Monday, October 27, 2025 at 12:30 PM at S88 Block Q Phase 2 Johar Town, Lahore, the head Office of the Company.

The Share Transfer Books of the Company will be closed from October 21, 2025 to October 27, 2025 (both days inclusive). Physical transfers / CDS Transaction IDs received at che Company's Share Registrar, M/s. F.D. Registrar Services (PVT) Ltd. 17th Floor, Saima Trade Tower-A, I.I. Chundrigar Road Karachi, at the close of business on October 20, 202a will be treated in time to determine voting rigfits of the shareholders for attending the meeting.

Company Secretary





sB8 Q oha Town Lañore Patstan jKM HeadBa ok Road Pñoo Naga.Dswmxasur Pa¥stan Hea6oWi,e:+92.tZ.35316587-9o | Fadory:+92.*9.t510189.+92.C9.4513392 wvw NGphamaiom.pk





23 13,353,52:t,857 2,409,238,742



24 111.13S,913,639J 110 823,O43,6 26)



2,0t7,608,3t7



{413,360.056J





?7 {329,672,942)







3,274,575.3 19







30 (462.470,896)



i7a,4I3,?02



489 667,362



833,4d3.847











Earlier from Citi Pharma

All Citi Pharma news releases